| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 94,293 | 84,100 | 70,393 | 65,115 | | Cost of Revenue | 64,488 | 65,544 | 54,337 | 57,425 | | | Gross Profit | 29,805 | 18,556 | 16,056 | 7,690 | | | Operating Expenses | | Research Development | 11,707 | 10,709 | 11,003 | 7,171 | | Selling General and Administrative | 10,848 | 9,233 | 8,973 | 6,815 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,250 | (1,386) | (3,920) | (6,296) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 445 | 451 | 397 | 178 | | Earnings Before Interest And Taxes | 7,695 | (935) | (3,523) | (6,118) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 7,695 | (935) | (3,523) | (6,118) | | Income Tax Expense | 1,472 | (135) | (1,060) | (3,136) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,223 | (800) | (2,463) | (2,982) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,223 | (800) | (2,463) | (2,982) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,223 | ($800) | ($2,463) | ($2,982) |
|
0.15% Nasdaq 
Income Statement
